Navigation Links
Syrupy Medicines Increase the Risk of Tooth Decay

A report published in the January/February issue of General Dentistry, the Academy of General Dentistry’s (AGD) clinical, peer-reviewed journal, says that most children's medicines have the potential to cause cavities since they have liberal doses of sugar in them. //

For example, antihistamine syrups contain a high level of sugar as well as low pH levels, which mean that they are high in acid content. The combination of the acidic content and sugar leads to the development of cavities. These medicines are usually available as over the counter preparations for allergies and flu or even cough. “It’s important to talk with your dentist about any medications that your child is on and see what he or she recommends to combat the problems those medications might cause,” said AGD spokesperson Paul Bussman, DMD, FAGD. But the report says that when treated with fluoride preparations the erosion of dental enamel was not so pronounced meaning that it resulted in fewer cavities. “Although some medications are necessary for general health they can be extremely harmful to the teeth if the medicine is given at bedtime or without following proper oral health habits,” observed Carolina Covolo da Costa, DDS, MSc, the author of the study.

The report adds that taking the medications at mealtimes minimizes the risk since the medicine is not in contact with the teeth for a long time. For more information, visit http://www.agd.org/media/2005/Dec/cavitiesasp
'"/>




Page: 1

Related medicine news :

1. Medicines on the move
2. Advent of New, More Effective and Personalized Medicines
3. Be Wary Of Heavy Metal Poisoning From Ayurvedic Medicines
4. Metal In Medicines Can Fight Diseases Effectively
5. Medicines Used In Antiplatelet Therapy Can Reduce Heart Attacks And Strokes
6. Heart Patients More At Risk Get Fewer Medicines
7. Export Of Ayurvedic Medicines Affected Due To High Heavy Metal Content
8. Herbal Medicines with Animal, Human Body Parts! - Swami Ramdev Accused
9. Anticholinergic Medicines Result In Cognitive Impairment
10. Wake Up Call: U.N Takes Stock to Curb Fake Medicines Racket
11. Health Minister Promises Strict Quality Control On Herbal Medicines
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...healthcare and food products major Dabur Group, is... capitalise on its plans to set// up a marine biot...iscovery center in Oman and using their marine res...Given that Oman has already committed to set up a ...
...today that properly-funded preschools must be made...a strong start to good health and wellbeing throug...onding to the Starting Strong II report, released ...of 20 OECD nations Australia had the lowest spendi...
...ly see a promotion of healthy foods in schools bec...3-million-a-year Nutrition fund. The Green Party ...art of its support agreement with the Labor-led Go... childhood centers will be able to apply for suppo...
...ing to the indiscriminate use of injection drugs, ...on// communiqué has put forward a recommendation t...ement, needle exchange and safer injections, with ...he disease. Taking cues from the report, countri...
Other Medicine News:Health News:Dabur Research to set up Drug Discovery Center in Oman 2Health News:Make Preschool Available To All Kids - AMA 2Health News:Better Nutrition in Schools Boosted by $12m Fund 2
(Date:9/3/2008)...alysis showed that Multaq(R) (dronedarone) decreas...l fibrillation or atrial flutter already ... BRIDGEWATER, N.J., Sept. 3 /PRNewswire-FirstCall/... from the ATHENA study were presented today at,the...iety of Cardiology,congress 2008, in Munich, Germa...
(Date:9/3/2008)...09 to be Evaluated in Repeat-Dosing Study in Subje...re-FirstCall/ -- Sangamo,BioSciences, Inc. (Nasdaq...se,2 clinical trial (SB-509-801) to evaluate its d...degenerative motor-neuron disease for which there,...mo,s drug, SB-509, is an injectable formulation of...
(Date:9/2/2008)...elegates Join World Vision, ONE to Build Hope and ...swire/ -- Delegates to the,Republican Party Conven...communities around the world including evacuees in...V and AIDS in developing countries: "We are here,t...nviting party delegates to do,something unconventi...
(Date:9/2/2008)...t of three ongoing randomized chemotherapy combina...atment of specific cancers -, ROCKVILLE, Md., Sep...es, Inc. (Nasdaq: HGSI ) today reported initial t...clinical trial of its TRAIL receptor antibody,HGS-...(Velcade) in patients,with advanced multiple myelo...
Breaking Medicine Technology:Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 2Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 3Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 4Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 2Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 3Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 4Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 5Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 6AWWA Urges Science Based Approach in Addressing Pharmaceutical Compounds in Water 16924 1AWWA Urges Science Based Approach in Addressing Pharmaceutical Compounds in Water 16924 2AWWA Urges Science Based Approach in Addressing Pharmaceutical Compounds in Water 16924 3Antioxidant users dont live longer analysis of studies concludes 2904 1Antioxidant users dont live longer analysis of studies concludes 2904 2Antioxidant users dont live longer analysis of studies concludes 2904 3Hereditary breast cancer a high cost to patient and health care provider alike 16918 1Hereditary breast cancer a high cost to patient and health care provider alike 16918 2Hereditary breast cancer a high cost to patient and health care provider alike 16918 3Senetek PLC Reports 2007 Financial Results 16915 1Senetek PLC Reports 2007 Financial Results 16915 2Senetek PLC Reports 2007 Financial Results 16915 3
...07. Giaconda Ltd (ASX: GIA) today,announced that t...ved the Company,s Investigational New Drug applica...aR to treat patients with,Crohn,s Disease infected...P). , ,The Company understands that its lead produ...d to the FDA for this indication. There,are no ant...
..., 2007 /PRNewswire-FirstCall/ --,Allos Therapeutic...,European Communities, with a favorable opinion of...e European Medicines Agency (EMEA),has granted or...olate PDX (pralatrexate) for the treatment of pati...ly 2006, the U.S. Food and,Drug Administration (FD...
Other Medicine Technology:FDA approves MyocondaR IND for MAP in Crohn's Disease 2FDA approves MyocondaR IND for MAP in Crohn's Disease 3FDA approves MyocondaR IND for MAP in Crohn's Disease 4Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 2Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 4
...iCharts, is a state-of-the-art electronic medical ...8. It is a proven, comprehensive electronic medica...are providers at the point of care and to be share...nternet. AmkaiCharts chronicles patient history, e...
...fice seamlessly integrates practice management and...nd clinical workflow. Instantly access registratio...eporting information for multiple practices, provi...tely improves productivity by simplifying office w...
The ReSeeVit Slit Lamp System is an easy-to-use digital video imaging system that captures anterior segment and retinal images for documentation, diagnosis and patient education. The package includes
...e is an important movement in our country to provi...ns. In fact, recent government regulations require...s device affords your wheelchair-bound patients ea...t without having to leave their wheelchair. , ,The...
Medicine Products: